published meta-analysis   sensitivity analysis   studies

vitamin C in COVID-19 severe or critically - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsZhang, 2020 0.50 [0.17; 1.50] 0.50[0.17; 1.50]Zhang, 202010%56NAnot evaluable deathsdetailed resultsZhang, 2020 0.50 [0.17; 1.50] 0.50[0.17; 1.50]Zhang, 202010%56NAnot evaluable deaths (time to event analysis only)detailed resultsZhang, 2020 0.50 [0.17; 1.50] 0.50[0.17; 1.50]Zhang, 202010%56NAnot evaluable clinical deteriorationdetailed resultsZhang, 2020 0.87 [0.23; 3.27] 0.87[0.23; 3.27]Zhang, 202010%56NAnot evaluable0.22.01.0relative treatment effectwww.metaEvidence.org2024-03-29 05:48 +01:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 91 - treatments: 523,885 - roots T: 290